Urology Medical News about neoadjuvant chemotherapy

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

What happens to the patients with muscle-invasive bladder cancer who refuse cystectomy after neoadjuvant chemotherapy
Indian Journal of Urology, 06/26/09

Maheshwari R et al. - Study highlights the fact that patients with muscle-invasive bladder cancer refusing cystectomy after chemotherapy are at high risk for disease-related mortality. At the same time, pts with small, clinically confined single tumors, which can be visibly and microscopically completely resected before neoadjuvant chemotherapy, are most likely to survive without cystectomy.

Methods

A prospective study to determine the outcome of pts who refuse cystectomy after receiving neoadjuvant chemotherapy
63 such pts evaluated between 1995-2001
Tumor and treatment features for a median f/u of 86 mo was assessed, all pts being followed-up for >5 yrs

Results

40 pts (64%) survived, with 54% of them having an intact functioning bladder
The number and size of invasive tumors were strongly associated with overall survival
The most significant treatment variable predicting better survival was complete resection of the invasive tumor on restaging transurethral resection (TUR) before starting chemotherapy
Of 23 pts (36%) who subsequently died of disease, 19 (30%) relapsed with invasive cancer in bladder
Over 90% of the surviving pts had solitary, small and low-stage invasive tumors completely resected; 83% survived w/o relapses in the bladder

<< Previous
Does antenatal pelvic floor muscle training prevent stress...

Next >>
PDT combined with Intravesical BCG instillation would form an...